Original Research

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study

Boeru G, Milanov I, De Robertis F, Kozubski W, Lang M, Rojas-Farreras S, Tomlinson M

Medical Devices: Evidence and Research 2013, 6:175-184

Published Date: 15 November 2013